Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DRIO 
DarioHealth Corp (DRIO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: DRIO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $39.25
1 Year Target Price $39.25
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.41% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 21.63M USD | Price to earnings Ratio - | 1Y Target Price 39.25 |
Price to earnings Ratio - | 1Y Target Price 39.25 | ||
Volume (30-day avg) 4 | Beta 1.24 | 52 Weeks Range 7.60 - 31.00 | Updated Date 08/29/2025 |
52 Weeks Range 7.60 - 31.00 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -13.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-12 | When - | Estimate -0.2 | Actual 0.18 |
Profitability
Profit Margin -162.73% | Operating Margin (TTM) -171.35% |
Management Effectiveness
Return on Assets (TTM) -22.55% | Return on Equity (TTM) -66.92% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 32824942 | Price to Sales(TTM) 0.8 |
Enterprise Value 32824942 | Price to Sales(TTM) 0.8 | ||
Enterprise Value to Revenue 1.21 | Enterprise Value to EBITDA -0.59 | Shares Outstanding 2274850 | Shares Floating 1993540 |
Shares Outstanding 2274850 | Shares Floating 1993540 | ||
Percent Insiders 38.12 | Percent Institutions 14.7 |
Upturn AI SWOT
DarioHealth Corp
Company Overview
History and Background
DarioHealth Corp. was founded in 2011. Initially focused on diabetes management solutions, it has evolved into a digital health company offering a broader suite of chronic condition management tools. Significant milestones include FDA clearances and strategic acquisitions expanding its platform.
Core Business Areas
- Digital Health Platform: Offers a comprehensive platform for managing various chronic conditions, including diabetes, hypertension, weight management, musculoskeletal (MSK) health, and behavioral health.
- Remote Patient Monitoring (RPM): Provides RPM solutions that allow healthcare providers to remotely monitor patients' health data, enabling personalized care and interventions.
- Employer Solutions: Partners with employers to offer digital health programs to their employees, aiming to improve employee health, reduce healthcare costs, and enhance productivity.
- Payor Solutions: Collaborates with health plans and payors to integrate its digital health platform into their offerings, providing value-based care and improved outcomes for their members.
Leadership and Structure
The leadership team consists of experienced executives in healthcare, technology, and finance. The organizational structure typically includes departments for technology, product development, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- Dario Blood Glucose Monitoring System: A smart blood glucose meter connected to a mobile app for real-time data tracking and personalized insights. Competitors include Dexcom (DXCM), Abbott (ABT), and Medtronic (MDT). Data unavailable to provide market share or revenue from product; the market is extremely competitive.
- Dario Hypertension Management: A program that combines blood pressure monitoring with digital coaching and support to help individuals manage hypertension. Competitors include Omron Healthcare, Qardio, and Withings. Data unavailable to provide market share or revenue from product; the market is extremely competitive.
- Dario Weight Management: A program focused on behavior change and personalized coaching to help individuals achieve and maintain a healthy weight. Competitors include WW International (WW), Noom, and Calibrate. Data unavailable to provide market share or revenue from product; the market is extremely competitive.
Market Dynamics
Industry Overview
The digital health market is experiencing rapid growth, driven by increasing adoption of telehealth, remote patient monitoring, and personalized healthcare solutions. Key trends include the rise of chronic disease management platforms and the integration of AI and data analytics.
Positioning
DarioHealth positions itself as a comprehensive digital health platform that addresses multiple chronic conditions. Its competitive advantages include its integrated platform, personalized coaching, and data-driven insights.
Total Addressable Market (TAM)
The total addressable market (TAM) for digital chronic condition management is estimated to be in the billions of dollars. DarioHealth is positioned to capture a portion of this market by expanding its platform and customer base.
Upturn SWOT Analysis
Strengths
- Comprehensive digital health platform
- Integrated solutions for multiple chronic conditions
- Personalized coaching and support
- Data-driven insights and analytics
- Strong partnerships with employers and payors
Weaknesses
- High customer acquisition costs
- Limited brand recognition compared to larger competitors
- Reliance on partnerships for distribution
- History of net losses
Opportunities
- Expanding into new chronic condition areas
- Increasing adoption of telehealth and RPM
- Growing demand for personalized healthcare solutions
- Strategic acquisitions and partnerships
- Penetrating international markets
Threats
- Increased competition from larger healthcare companies
- Changes in healthcare regulations and reimbursement policies
- Data privacy and security concerns
- Economic downturn impacting healthcare spending
- Lack of demonstrated ROI for payers
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Livongo (now part of Teladoc Health)
- Omada Health (Private)
- WW International (WW)
- Noom (Private)
Competitive Landscape
DarioHealth faces intense competition from established players in the digital health market. It must differentiate itself through its comprehensive platform, personalized solutions, and strong partnerships.
Major Acquisitions
WayForward
- Year: 2021
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expanded DarioHealth's offerings into behavioral health.
Upright Health
- Year: 2021
- Acquisition Price (USD millions): 19
- Strategic Rationale: Expanded DarioHealth's offerings into musculoskeletal health.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been focused on revenue growth through strategic acquisitions and new partnerships.
Future Projections: Future growth is projected to be driven by increasing adoption of digital health solutions and expansion into new markets. However, the company's path to profitability remains uncertain.
Recent Initiatives: Recent initiatives include launching new digital health programs, expanding partnerships with employers and payors, and investing in technology development.
Summary
DarioHealth Corp. is a digital health company with a comprehensive platform for managing chronic conditions. Its strengths lie in its integrated solutions and personalized coaching. However, the company faces challenges including high customer acquisition costs and intense competition. Future growth will depend on its ability to expand its platform, secure new partnerships, and achieve profitability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Press releases
- Market research reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made in consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DarioHealth Corp
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2014-10-06 | CEO & Director Mr. Erez Raphael | ||
Sector Healthcare | Industry Health Information Services | Full time employees 196 | Website https://www.dariohealth.com |
Full time employees 196 | Website https://www.dariohealth.com | ||
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.